Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1964
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 3
1968 1
1969 3
1971 3
1972 3
1973 1
1974 6
1975 3
1976 3
1977 4
1978 3
1979 5
1980 3
1981 3
1982 4
1983 6
1984 4
1986 4
1987 4
1988 13
1989 8
1990 6
1991 7
1992 6
1993 12
1994 17
1995 12
1996 15
1997 10
1998 7
1999 10
2000 7
2001 10
2002 3
2003 8
2004 9
2005 16
2006 8
2007 15
2008 6
2009 8
2010 14
2011 13
2012 14
2013 12
2014 10
2015 14
2016 16
2017 16
2018 17
2019 12
2020 12
2021 5
2022 10
2023 7
2024 5
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

435 results

Results by year

Filters applied: . Clear all
Page 1
Gastroenteropancreatic Neuroendocrine Tumors.
Cives M, Strosberg JR. Cives M, et al. CA Cancer J Clin. 2018 Nov;68(6):471-487. doi: 10.3322/caac.21493. Epub 2018 Oct 8. CA Cancer J Clin. 2018. PMID: 30295930 Free article. Review.
Multiple retrospective series have reported the efficacy of liver-directed therapies both for palliating symptoms of hormone excess and for controlling tumor growth. Telotristat, an oral inhibitor of tryptophan hydroxylase, has been shown to reduce diarrhea in patients wit …
Multiple retrospective series have reported the efficacy of liver-directed therapies both for palliating symptoms of hormone excess and for …
Gastroenteropancreatic Neuroendocrine Tumors.
Fernandes CJ, Leung G, Eads JR, Katona BW. Fernandes CJ, et al. Gastroenterol Clin North Am. 2022 Sep;51(3):625-647. doi: 10.1016/j.gtc.2022.06.002. Epub 2022 Aug 30. Gastroenterol Clin North Am. 2022. PMID: 36153114 Review.
Somatostatin Analogs in Clinical Practice: a Review.
Gomes-Porras M, Cárdenas-Salas J, Álvarez-Escolá C. Gomes-Porras M, et al. Int J Mol Sci. 2020 Feb 29;21(5):1682. doi: 10.3390/ijms21051682. Int J Mol Sci. 2020. PMID: 32121432 Free PMC article. Review.
Somatostatin analogs have also shown to be useful in the treatment of other endocrine diseases (congenital hyperinsulinism, Graves' orbitopathy, diabetic retinopathy, diabetic macular edema), non-endocrine tumors (breast, colon, prostate, lung, and hepatocellular), and digestive …
Somatostatin analogs have also shown to be useful in the treatment of other endocrine diseases (congenital hyperinsulinism, Graves' orbitopa …
Neuroendocrine Neoplasms.
Kamboj S, Guerra-Bauman F, Mahmud H, Waheed A. Kamboj S, et al. Prim Care. 2024 Sep;51(3):549-560. doi: 10.1016/j.pop.2024.04.010. Epub 2024 May 23. Prim Care. 2024. PMID: 39067978 Review.
Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future.
Stueven AK, Kayser A, Wetz C, Amthauer H, Wree A, Tacke F, Wiedenmann B, Roderburg C, Jann H. Stueven AK, et al. Int J Mol Sci. 2019 Jun 22;20(12):3049. doi: 10.3390/ijms20123049. Int J Mol Sci. 2019. PMID: 31234481 Free PMC article. Review.
Beyond symptomatic management, recent research demonstrates that SSAs exert antiproliferative effects and inhibit tumor growth via the somatostatin receptor 2 (SSTR2). Both the PROMID (placebo-controlled, prospective, randomized study in patients with metastatic neuroendoc …
Beyond symptomatic management, recent research demonstrates that SSAs exert antiproliferative effects and inhibit tumor growth via th …
Goblet cell adenocarcinoma of the appendix: an update and practical approach to diagnosis and grading.
Bell PD, Pai RK. Bell PD, et al. Hum Pathol. 2023 Feb;132:183-196. doi: 10.1016/j.humpath.2022.06.002. Epub 2022 Jun 9. Hum Pathol. 2023. PMID: 35691370 Review.
These tumors have engendered considerable confusion in the literature regarding their classification, and they have been described under several different names including goblet cell carcinoid, adenocarcinoid, and adenocarcinoma, among others. In the recent fifth edition o …
These tumors have engendered considerable confusion in the literature regarding their classification, and they have been described under sev …
Appendix Tumor Microenvironment.
Roncati L, Gasparri P, Gallo G, Bernardelli G, Zanelli G, Manenti A. Roncati L, et al. Adv Exp Med Biol. 2020;1226:87-95. doi: 10.1007/978-3-030-36214-0_7. Adv Exp Med Biol. 2020. PMID: 32030678 Review.
Moreover, different types of lymphomas, Hodgkin and non-Hodgkin, arising from the extra-nodal mucosal-associated lymphatic tissue, can be encountered. The appendix tumor microenvironment (TME) consists of a cellular component and of a noncellular component: the former incl …
Moreover, different types of lymphomas, Hodgkin and non-Hodgkin, arising from the extra-nodal mucosal-associated lymphatic tissue, can be en …
Goblet cell adenocarcinoma.
Veerapong J, Hosseini M. Veerapong J, et al. Semin Diagn Pathol. 2024 Sep;41(5):230-234. doi: 10.1053/j.semdp.2024.08.003. Epub 2024 Aug 15. Semin Diagn Pathol. 2024. PMID: 39181727 Review.
Among the appendiceal tumors, goblet cell adenocarcinoma (GCA) is a rare primary epithelial neoplasm which has undergone multiple name changes and classifications in recent years, adding to confusion surrounding this unique amphicrine tumor. This entity was previously know …
Among the appendiceal tumors, goblet cell adenocarcinoma (GCA) is a rare primary epithelial neoplasm which has undergone multiple name chang …
Carcinoid tumors.
Pinchot SN, Holen K, Sippel RS, Chen H. Pinchot SN, et al. Oncologist. 2008 Dec;13(12):1255-69. doi: 10.1634/theoncologist.2008-0207. Epub 2008 Dec 17. Oncologist. 2008. PMID: 19091780 Free PMC article. Review.
Carcinoid tumors are rare, slow-growing neuroendocrine tumors arising from the enterochromaffin cells disseminated throughout the gastrointestinal and bronchopulmonary systems. ...Similarly, treatment of both primary and disseminated carcinoid disease reflects the n
Carcinoid tumors are rare, slow-growing neuroendocrine tumors arising from the enterochromaffin cells disseminated throughout the gas
Carcinoid tumors.
Robertson RG, Geiger WJ, Davis NB. Robertson RG, et al. Am Fam Physician. 2006 Aug 1;74(3):429-34. Am Fam Physician. 2006. PMID: 16913162 Free article. Review.
Carcinoid tumors derive from different embryonic divisions of the gut: foregut carcinoid tumors commonly originate in the lungs, bronchi, or stomach; midgut carcinoid tumors in the small intestine, appendix, or proximal large bowel; and hindgut carc
Carcinoid tumors derive from different embryonic divisions of the gut: foregut carcinoid tumors commonly originate in the lung
435 results